Stockreport

Skye Bioscience Provides 2025 Look Ahead and Year in Review

Skye Bioscience, Inc.  (SKYE) 
PDF SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company developing new therapeutic pathw [Read more]